Quest Corp (DGX) - Long-Term Debt to Capital Ratio

Corporate emblem and logo of Quest Diagnostics (DGX)

This price chart, which assists in the fundamental valuation of Quest Diagnostics (DGX), a company specializing in laboratory diagnostics, shows the 0.78 indicator. The business remains independent of economic cycles and macroeconomic shocks due to medical insurance. Risks are limited solely to a potential shortage of Asian reagents. Meanwhile, a streamlined courier delivery system for biomaterials ensures the uninterrupted operation of the center network and eliminates supply chain disruptions.

Quest Corp (DGX): Long-Term Debt to Equity from 07/04/2022 to 10/29/2026

Analytical breakdowns for Quest Diagnostics

- market price and analyst price targets:
Market Price Quest Diagnostics Inc.|DGX - Analyst Consensus Forecast
- market capitalization indicators:
Market Capitalization Quest Diagnostics Incorporated|DGX - Enterprise Value
- issuer book value statistics:
Book Value per Share Quest Diagnostics|DGX - Company Book Value|Capitalization to Book Value Ratio questdiagnostics.com|DGX - Company Total Assets
- debt and solvency information:
Total Debt to Capital Quest Diagnostics|DGX - Long-Term Debt to Equity|Short-Term Debt to Equity questdiagnostics.com|DGX - Company Total Debt|Debts to Book Value Quest Diagnostics Incorporated|DGX - Company Long-Term Debt|Short-Term Debt Volume Quest Diagnostics|Interim Coverage Ratio questdiagnostics.com
- net income and valuation ratios data:
DGX - Company Net Income
General company analysis:DGX (Quest Diagnostics Inc.)
Core merchandise of questdiagnostics.com

Quest Diagnostics bases its development on the aggressive acquisition of local laboratories to scale testing volumes and optimize costs. The ratio of long-term liabilities to equity within the dynamics of long-term debt-to-capital allows for an assessment of debt service risk amid changes in asset market value, determining the balance between financial stability and the pace of business expansion.

Analysis of competing companies

Long-Term Liabilities to Capital Agilent Technologies, Inc. A|Long-Term Debt to Capital ILMN|Exact Sciences Inc. - Long-Term Debt to Capital Ratio|Long-Term Debt to Capital RVTY (Revvity, Inc.)|Long-Term Debt to Capital bio-rad.com BIO|NNNN - Long-Term Debt to Equity|SHC (Sotera Health Corp) - Long-Term Debt to Capital Ratio|QDEL: Long-Term Debt to Capital|OPKO Health Corp. (OPK) - Long-Term Debt to Capital|Long-Term Debt to Equity CareDx Inc|Long-Term Debt to Equity MRVI|Long-Term Debt to Equity Ratio FLGT (Fulgent Genetics)|LAB - Long-Term Liabilities to Capital|Long-Term Debt to Equity Cytek Bio CTKB|Ratio of Long-Term Indebtedness to Capital OraSure Corp (OSUR)|Exagen Diagnostics - Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital mdxhealth.com MDXH|Lucid Diagnostics (LUCD) - Long-Term Debt to Equity|PRE - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Insight Molecular Diagnostics, Inc.|TRIB - Long-Term Indebtedness to Equity|Long-Term Debt to Equity Ratio PRPH (ProPhase Labs, Inc.)|Long-Term Debt to Capital ainos.com (AIMD)|Long-Term Debt to Capital CODX (Co-Diagnostics)|Heart Test Laboratories, Inc. (HSCS) - Long-Term Liabilities to Capital|BMRA - Long-Term Debt to Equity|Ratio of Long-Term Indebtedness to Capital Cardio Diagnostics CDIO|VRAX (Virax Biolabs Group) - Long-Term Debt to Equity Ratio|BJDX: Long-Term Loans to Capital Ratio|Long-Term Debt to Equity Ratio AWH|AXDX: Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital CNTG|enzo.com - Long-Term Debt to Capital Ratio|Long-Term Debt to Capital FRES (Fresh2 Group)|Ratio of Long-Term Indebtedness to Capital Genetic Technologies Ltd (GENE)|23andMe - Long-Term Debt to Capital|PMD - Long-Term Debt to Capital